Closed-loop DBS for depression

Closed-loop (adaptive or responsive) deep-brain stimulation for depression senses an ongoing neural biomarker of pathological state and delivers stimulation only when that state is detected, instead of stimulating continuously at fixed parameters (open-loop). The rationale is that mood disorders are episodic and state-dependent, so responsive delivery could in principle improve efficacy, reduce habituation and off-target side effects, and conserve battery.

As of the early 2020s this remains largely at the single-patient and small-cohort proof-of-concept stage. The landmark demonstration decoded a personalized limbic biomarker in one patient and triggered ventral-striatal stimulation only when that biomarker crossed threshold; no closed-loop psychiatric DBS system has regulatory approval or a completed efficacy randomized controlled trial. The read side (a reliable state detector) is the binding constraint, not the stimulation hardware.